Nan Fung Group Holdings’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-36,847
| Closed | -$187K | – | 45 |
|
|
2024
Q1 | $187K | Buy |
36,847
+19,000
| +106% | +$96.5K | 0.17% | 41 |
|
|
2023
Q4 | $107K | Hold |
17,847
| – | – | 0.07% | 34 |
|
|
2023
Q3 | $126K | Hold |
17,847
| – | – | 0.1% | 34 |
|
|
2023
Q2 | $126K | Hold |
17,847
| – | – | 0.08% | 40 |
|
|
2023
Q1 | $149K | Buy |
+17,847
| New | +$149K | 0.1% | 38 |
|
|
2022
Q1 | – | Sell |
-15,545
| Closed | -$215K | – | 47 |
|
|
2021
Q4 | $215K | Buy |
+15,545
| New | +$215K | 0.06% | 46 |
|